Team
Our team includes University Professors in Microfluidics and Bioinformatics , as well as experts in entrepreneurship, business administration, cancer biology and biomedical sciences.
Christoph is a professor for biomedical microfluidics at EPFL and holds an adjunct position at the Ludwig Institute for Cancer Research. In parallel to his academic career,christoph has successfully commercialized microfluidic technology for genomic applications and collaborated with big pharma. Furthermore, he is a cofounder and CSO of Velabs Therapeutics.
Prof. Christoph A. Merten
Swiss Federal Institute of Technology Lausanne (EPFL), Ludwig Institute for Cancer Research Adjunct scientist. Expert in biomedical microfluidics
Federica is an Assistant Professor of Systems Biology for Oncology at Eindhoven University of Technology in the Netherlands. She is an expert in personalized cancer therapies. Her approach combines both data science and experimental methods. She is the lead author of numerous articles in high-impact journals.
Prof. Federica Eduati
Eindhoven Technical University Expert in Biomedical Engineering and computational biology
Vida has 15 years of research experience in tumor biomarkers, signal transduction, chemotherapy resistance and immuno-oncology. She has expertise in preclinical cancer research and is an experienced project manager. She leads the project in vivo validation unit.
Dr. Vida Vafaizadeh
Swiss Federal Institute of Technology Lausanne (EPFL), School of Engineering, Department of Bioengineering. Head of clinical development
Hana is an EPFL Micro-engineer with entrepreneurial background in tech driven innovation. she has collaborated with successful startups in the medical device space. As a previous medtech startup founder, she has hands-on experience of both product development and venture strategies. She leads the project's technology development unit.
Hana Samet
Swiss Federal Institute of Technology Lausanne (EPFL), School of Engineering, Department of Bioengineering. Head of microfluidic tech development
Hien is a molecular biologist by training. She has been working on cellular genetics and transcriptomics explaining individual differences in circadian traits that are often disrupted in human diseases. She leads the transcriptomic unit.
Dr. Ngoc-Hien DU
Swiss Federal Institute of Technology Lausanne (EPFL), School of Engineering, Department of Bioengineering. Head of sequencing technologies
